Opaleye Management Inc. Protara Therapeutics, Inc. Transaction History
Opaleye Management Inc.
- $548 Million
- Q3 2024
A detailed history of Opaleye Management Inc. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 1,681,154 shares of TARA stock, worth $8.27 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
1,681,154
Previous 2,304,262
27.04%
Holding current value
$8.27 Million
Previous $4.79 Million
35.81%
% of portfolio
0.56%
Previous 1.23%
Shares
9 transactions
Others Institutions Holding TARA
# of Institutions
39Shares Held
10.7MCall Options Held
9KPut Options Held
1.8K-
Ra Capital Management, L.P. Boston, MA1.9MShares$9.35 Million0.05% of portfolio
-
Stem Point Capital LP New York, NY943KShares$4.64 Million0.52% of portfolio
-
Woodline Partners LP San Francisco, CA852KShares$4.19 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA812KShares$3.99 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA760KShares$3.74 Million0.0% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $55.4M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...